Analysis of the role of the B cell inhibitory receptor Siglec-G in autoimmunity and infection models
Analysis of the role of the B cell inhibitory receptor Siglec-G in autoimmunity and infection models
批准号:
109957018
负责人:
Professor Dr. Lars Nitschke
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2009
资助国家:
德国
项目状态:
未结题
起止时间:
2008-12-31 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Siglec proteins are a family of inhibitory receptors on immune cells. We recently characterized Siglec-G as a new member of this family. Siglec-G is expressed on B lymphocytes and has a specific role as inhibitory receptor on the B1 cell subset in the mouse. This was found in Siglec- G-deficient mice with have a large expansion of B1 cells and increased B1 cell Ca2+ responses. This proposal addresses the role of Siglec-G in systemic autoimmunity and anti-bacterial immunoglobulin responses which will be studied during a research visit in a lab at Cambridge University.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Die Rolle des Adaptorproteins Grb2 für die Reifung und Aktivierung von B- und T-Lymphozyten
-
批准号:169992032
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Lars Nitschke
-
依托单位:
Untersuchungen zur Rolle von CD22 und Siglec-G in der Regulation von B-Zell-Aktivierung und systemischer Autoimmunität
-
批准号:38109987
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Professor Dr. Lars Nitschke
-
依托单位:
Regulation of differentiation in myeloid cells and B-cells by the adhesion recepters of the siglec family
-
批准号:5412712
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Professor Dr. Lars Nitschke
-
依托单位:
The importance of sialoglycans for lymphocyte development and function
-
批准号:432178797
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Lars Nitschke
-
依托单位:
CD22 and its regulation of BCR signaling strength in germinal center B cell fate and metabolism
-
批准号:528069786
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Lars Nitschke
-
依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
-
批准号:82371070
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵培泉
-
依托单位: